| 영문 | acetylsalicylic acid | 한글 | 아세틸살리실산 |
|---|---|---|---|
| 설명 | 상품명이 아스피린(asprin)인 약. 대표적인 비스테로이드 항염약이다. 즉 항염증(anti-inflammatory), 진통(analgesis), 해열(anti-pyretic)의 효과가 모두 뛰어나지만 위장장애, 과다호흡, 라이증후군(Reye syndrome) 등의 부작용이 있다. |
||
| 영문 | uric acid | 한글 | 요산 |
|---|---|---|---|
| 설명 | 결정성의 산. 2, 6, 8-trioxypurine. 화학식은 C5H4N4O3로 사람과 동물의 오줌에서 얻을 수 있다. 핵의 대사산물의 하나. 물, 알콜, 에테르(ether)에는 거의 녹지 않으나 알칼리염의 용액에는 녹는다. 이것의 나트륨염 형태(sodium urate)가 결석의 대부분을 차지한다. 급성백혈병 치료 초기단계와 통풍(Gout)에서 혈중요산이 급격히 오를 수 있다. |
||
| 영문 | acid-fast bacillus | 한글 | 항산막대균, 항산균 |
|---|---|---|---|
| 설명 | 아닐린 색소에 염색되기 힘드나 일단 염색되면 강산으로 처리하여도 탈색되지 아니하는 세균을 통틀어 이르는 말. 결해균, 나병균 따위가 있다. |
||
| 영문 | acid-fast staining | 한글 | 항산염색 |
|---|---|---|---|
| 설명 | 항산성성질(좀처럼 염색이 되지 않으나 한번 염색이 되면 산성용액에 의해서 탈색이 되지 않는 성질)을 가진 균(예를 들면 결핵균 등)의 검출에 이용되는 염색방법. 방법에는 Ziehl-Neelson법과 Kinyoun법 등이 있다. |
||
| 영문 | nucleic acid | 한글 | 핵산 |
|---|---|---|---|
| 설명 | 염기, 당, 인산으로 이루어진 뉴클레오티드가 긴 사슬 모양으로 중합된 고분자 물질. 유전이나 단백질 합성을 지배하는 중요한 물질로, 생물의 증식을 비롯한 생명 활동 유지에 중요한 작용을 한다. 구성 당인 오탄당이 리보오스인 리보핵산과 디옥시리보오스인 디옥시리보 핵산으로 나뉜다. 펜토스로서 리보스나 데옥시리보스 어느 한쪽만을 포함하며 전자를 리보핵산(RNA), 후자를 데옥시리보핵산(deoxyribonucleic acid, DNA)이라 부른다. 모두 4종류의 유기염기에 의해 특징지어지며 아데닌, 구아닌 및 시토신은 양자에 공통이다. 티민은 DNA에, 우라실은 RNA에 포함된다. DNA는 주로 핵에 존재하며 형질유전에 그리고 RNA는 세포질속에서 단백질 합성에 관여한다. 섭취된 핵산은 소화관에서 구성분자로까지 가수분해되어 흡수된다. |
||
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
|---|---|
| AA | abdominal aorta; acetic acid; achievement age; active alcoholic; active assistive [range of motion];... |
| OA | obstructive apnea; occipital artery; occipito-anterior; occiput anterior; octanoic acid; ocular albi... |
| PAA | partial agonist activity; phenylacetic acid; phosphonoacetic acid; physical abilities analysis; plas... |
| ASA | acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes... |
| muscarinic antagonists | Drugs that bind to but do not activate muscarinic cholinergic receptors (receptors, muscarinic), thereby blocking the actions of endogenous acetycholine or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. Antagonists that discriminate among the various muscarinic receptor subtypes and might allow better control of peripheral and central actions are under development. (12 Dec 1998) |
|---|---|
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| prostaglandin antagonists | Compounds that inhibit the action of prostaglandins. (12 Dec 1998) |
| histamine antagonists | Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonist. Classical antihistaminics block the histamine h1 receptors only. (12 Dec 1998) |
| histamine h1 antagonists | Drugs that selectively bind to but do not activate histamine h1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonise or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system h1 receptors are not as well understood. (12 Dec 1998) |
| histamine h2 antagonists | Drugs that selectively bind to but do not activate histamine h2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (12 Dec 1998) |
| hormone antagonists | Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (12 Dec 1998) |
| hormones, hormone substitutes, and hormone antagonists | A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists. (12 Dec 1998) |
| serotonin antagonists | Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonin agonists. (12 Dec 1998) |
| narcotic antagonists | Agents inhibiting the effect of narcotics on the central nervous system. (12 Dec 1998) |
| nicotinic antagonists | Drugs that bind to nicotinic cholinergic receptors (receptors, nicotinic) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (12 Dec 1998) |
| dopamine antagonists | Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (antipsychotic agents) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as antiemetics, in the treatment of tourette syndrome, and for hiccup. (12 Dec 1998) |
| opioid antagonists | Agents such as naloxone and naltrexone which have high affinity for opiate receptors but do not activate these receptors. These drugs block the effects of exogenously administered opioids such as morphine, heroin, meperidine, and methadone, or of endogenously released endorphins and enkephalins. (05 Mar 2000) |
| estradiol antagonists | Compounds which inhibit or antagonise the biosynthesis or action of estradiol. (12 Dec 1998) |
| 5-hydroxy tryptamine antagonists | Agents which block serotonin receptors and hence interfere with the biological actions of serotonin (5-HT). (05 Mar 2000) |